IRADIMED CORP (IRMD) Form 10-Q — Oct 30, 2026
IRadimed (IRMD) reported Q3 2026 revenue of $24.2 million, up 14% year over year, with net income of $6.5 million, or $0.51 per diluted share, up from $5.6 million and $0.43 a year ago. International revenue was the standout, up 45% to $4.5 million, while monitoring system sales rose 17% and disposables grew 21%. Gross margin slipped to 76% from 78% on new-product production ramp inefficiencies. The company holds $63.3 million in cash with no debt, generated $21.2 million in nine-month operating cash flow, and declared a $0.20 per share quarterly dividend payable November 27, 2026.
Key figures
- Eps
- 0.51
- Revenue
- 24203000
- Net Income
- 6506000
- Revenue Yoy
- 14%
- Cash Position
- 63288000
- Shares Outstanding
- 12788153
- Gross margin q3
- 76%
- Working capital
- 82500000
- Nine month revenue
- 66648000
- Nine month net income
- 17542000
- Operating cash flow 9m
- 21227000
- Quarterly dividend per share
- 0.2
- International revenue growth q3
- 45%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.